A Novel Strategy for the Treatment of Aneurysms: Inhibition of MMP-9 Activity through the Delivery of TIMP-1 Encoding Synthetic mRNA into Arteries
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25126599 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Sonia Golombek und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic and Cardiovascular Surgery, University Hospital Tuebingen, Calwerstraße 7/1, 72076 Tuebingen, Germany. Hauptthemen laut MEDLINE: Tissue Inhibitor of Metalloproteinase-1, Matrix Metalloproteinase 9, RNA, Messenger. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Open Access Publishing Fund of the University of Tübingen.
Abstract (Originalsprache)
Aneurysms pose life-threatening risks due to the dilatation of the arteries and carry a high risk of rupture. Despite continuous research efforts, there are still no satisfactory or clinically effective pharmaceutical treatments for this condition. Accelerated inflammatory processes during aneurysm development lead to increased levels of matrix metalloproteinases (MMPs) and destabilization of the vessel wall through the degradation of the structural components of the extracellular matrix (ECM), mainly collagen and elastin. Tissue inhibitors of metalloproteinases (TIMPs) directly regulate MMP activity and consequently inhibit ECM proteolysis. In this work, the synthesis of TIMP-1 protein was increased by the exogenous delivery of synthetic TIMP-1 encoding mRNA into aortic vessel tissue in an attempt to inhibit MMP-9. In vitro, TIMP-1 mRNA transfection resulted in significantly increased TIMP-1 protein expression in various cells. The functionality of the expressed protein was evaluated in an appropriate ex vivo aortic vessel model. Decreased MMP-9 activity was detected using in situ zymography 24 h and 48 h post microinjection of 5 µg TIMP-1 mRNA into the aortic vessel wall. These results suggest that TIMP-1 mRNA administration is a promising approach for the treatment of aneurysms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic and Cardiovascular Surgery, University Hospital Tuebingen, Calwerstraße 7/1, 72076 Tuebingen, Germany.
ORCID-Profile: Sonia Golombek, Meltem Avci-Adali
Förderung
- Open Access Publishing Fund of the University of Tübingen
Zitieren
APA
Golombek, S., Doll, I., Kaufmann, L., Lescan, M., Schlensak, C., & Avci-Adali, M. (2024). A Novel Strategy for the Treatment of Aneurysms: Inhibition of MMP-9 Activity through the Delivery of TIMP-1 Encoding Synthetic mRNA into Arteries. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25126599
Vancouver
Golombek S, Doll I, Kaufmann L, Lescan M, Schlensak C, Avci-Adali M. A Novel Strategy for the Treatment of Aneurysms: Inhibition of MMP-9 Activity through the Delivery of TIMP-1 Encoding Synthetic mRNA into Arteries. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25126599
BibTeX
@article{Golombek2024,
author = {Golombek, Sonia and Doll, Isabelle and Kaufmann, Louisa and Lescan, Mario and Schlensak, Christian and Avci-Adali, Meltem},
title = {A Novel Strategy for the Treatment of Aneurysms: Inhibition of MMP-9 Activity through the Delivery of TIMP-1 Encoding Synthetic mRNA into Arteries},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25126599}
}
EUVIMED